Tracking gluten immunoreactive peptides from the grain to the gut and beyond

Información del proyecto

GLUTENOMICS

Identificador del acuerdo de subvención: 101040437

DOI

10.3030/101040437

Fecha de la firma de la CE 19 Abril 2022

Fecha de inicio 1 Septiembre 2022

Fecha de finalización 31 Agosto 2027

Financiado con arreglo a

• European Research Council (ERC)

Coste total

€ 1 499 988,00

Aportación de la UE

€ 1 499 988,00

Coordinado por

LEIBNIZ-INSTITUT FUER LEBENSMITTEL-SYSTEMBIOLOGIE AN DER TECHNISCHEN UNIVERSITAET MUENCHEN
Germany

Periodic Reporting for period 1 - GLUTENOMICS (Tracking gluten immunoreactive peptides from the grain to the gut and beyond)

Período documentado: 2022-09-01 hasta 2025-02-28

Resumen del contexto y de los objetivos generales del proyecto

Wheat is one of the pillars for nutrition security worldwide, but the prevalence of wheat-related disorders (WRD) is increasing. Taken together, coeliac disease, non-coeliac gluten sensitivity and wheat food allergy may affect up to 10% of European individuals. The causes for this increase are still unknown, but involve the intricate interaction of proteolytically resistant gluten immunoreactive peptides (GIP) from wheat, rye and barley, the human immune system and yet unknown adjuvants. Total GIP can be detected by immunoassays in human plasma, urine and faeces (biosamples) after gluten consumption, but the precise molecular structures have not been clarified so far, because specific analytical methods are missing.
The project GLUTENOMICS aims to elucidate the molecular structures of GIP in human biosamples and analyse factors determining their identities and quantities. The central hypothesis is that gluten structure and content determine its digestibility which, in turn, leads to different GIP profiles in biosamples from healthy individuals and WRD patients. The findings will pave the way to tailor grain-based foods towards better tolerability to prevent the initial onset of WRD.

Trabajo realizado desde el comienzo del proyecto hasta el final del período abarcado por el informe y los principales resultados hasta la fecha

We investigated the presence of peptides with coeliac disease (CD)-active epitope in the five wheat species common wheat, spelt, durum wheat, emmer, and einkorn. In total, 494 peptides with CD-active epitope were identified. Considering the average of the eight cultivars of each species, spelt contained the highest number of different peptides with CD-active epitope (193 ± 12, mean ± SD). Einkorn showed the smallest variability of peptides (63 ± 4) but higher amounts of certain peptides compared to the other species.
A comprehensive database with proteins from wheat, rye, and barley containing known immunoreactive epitopes in the context of WRD and similar proteins not yet known to be immunoreactive for the in silico prediction of GIP was created. To compare gluten digestibility and the GIP profile of different flours, bread, and cakes after static in vitro digestion, the workflow was established from the food to discovery proteomics measurement and data analysis by optimizing all relevant steps including peptide clean-up, drying, dissolving and diluting the peptides, the proteomics measurement, and data evaluation. Following the successful optimization of the workflow for static in vitro digestion, different foods are now being prepared and studied using discovery proteomics.

Avances que van más allá del estado de la técnica e impacto potencial esperado (incluida la repercusión socioeconómica y las implicaciones sociales más amplias del proyecto hasta la fecha)

The accurate quantitation of gluten in supposedly gluten-free products still represents a major challenge, especially for rye and barley, because gluten contamination from these two grains is usually either over- or underestimated using current analytical methods that are calibrated to wheat. We addressed the current lack of appropriate reference materials and, for the first time, developed reference materials for rye and barley that will significantly increase food safety for celiac disease patients. In addition to the availability of the rye and barley flours mixtures to be used as reference materials, we also produced prolamin, glutelin and gluten isolates which have excellent storage properties.

Number of peptides with CD-active epitope that are unique or shared